Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong
1Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
2Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
3Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China; Hong Kong Institute of Diabetes and Obesity, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China; Li Ka Shing Institute of Health Sciences, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China
4Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong Special Administrative Region, People’s Republic of China; Hong Kong Hospital Authority, Hong Kong Special Administrative Region, People’s Republic of China
* Correspondence: andrealuk@cuhk.edu.hk
PLOS Medicine — Volume 20, Issue 1 (2023-01)
Abstract
Cite This Article
Wu, H., Lau, E., Yang, A., Zhang, X., Fan, B., Ma, R., Kong, A., Chow, E., So, W., Chan, J., Luk, A. (2023). Age-specific population attributable risk factors for all-cause and cause-specific mortality in type 2 diabetes: An analysis of a 6-year prospective cohort study of over 360,000 people in Hong Kong. PLOS Medicine, 20(1), online. https://doi.org/10.1371/journal.pmed.1004173
Related Articles
Risk of fracture in adults with type 2 diabetes in Sweden: A national cohort study
Axelsson K., Litsne H., Kousoula K., Franzén S., Eliasson B., Lorentzon M.
Outcome of COVID-19 in hospitalised immunocompromised patients: An analysis of the WHO ISARIC CCP-UK prospective cohort study
Drake T., Docherty A., Semple M., Baillie J., Harrison E., Openshaw P., Law A., Leeming G., Hardwick H., de Silva T., Richter A., Wootton D., Ho A., Aston S., Russell C., Palmieri C., Swets M., Turtle L., Thorpe M.
Associations between β-blockers and psychiatric and behavioural outcomes: A population-based cohort study of 1.4 million individuals in Sweden
Fazel S., Kaddoura S., Kuja-Halkola R., Larsson H., Lichtenstein P., D’Onofrio B., Molero Y.
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study
Timpson N., Ghazal P., Davey Smith G., Mitchell R., Khandaker G., MacGowan A., Hingorani A., Summers C., Baillie K., Maskell N., Mentzer A., Moran E., Palmer T., Arnold D., Thomas M., Hamilton F.